유럽집행위원회, 23 종의 CMR 물질 화장품 사용 금지
유럽집행위원회(European Commission)은 화장품 규정 부속서를 수정하여 23종의 발암성·돌연변이성·생식독성(carcinogenicity, mutagenicity, reproductive toxicity, CMR) 물질에 대해 화장품 내 사용하는 것을 금지하는 규정을 발표하였다.
개정된 규정에 따라 면제대상이 되지 않는 한 화장품 내 CMR 물질 사용이 금지된다. 금지사항은 2022년 3월 1일부터 시행되며, 새롭게 금지대상이 되는 물질은 아래와 같다.
Chemical Name |
CAS No. |
EC No. |
Silicon carbide fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1) |
409-21-2 308076-74-6 |
206-991-8 |
Tris(2-methoxyethoxy) vinylsilane; 6-(2-methoxyethoxy)- 6-vinyl-2,5,7,10-tetraoxa-6-silaundecane |
1067-53-4 |
213-934-0 |
Dioctyltin dilaurate; [1] stannane, dioctyl-, bis (coco acyloxy) derivs. [2] |
3648-18-8 [1] 91648- 39-4 [2] |
222-883-3 [1] 293-901-5 [2] |
Dibenzo[def,p]chrysene; dibenzo[a,l]pyrene |
191-30-0 |
205-886-4 |
Ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1- (1H-1,2,4-triazol-1-ylmethyl)cyclopentanol |
125225-28-7 115850-69-6 115937-89-8 |
- |
Bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme |
143-24-8 |
205-594-7 |
Paclobutrazol (ISO); (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl- 2-(1H-1,2,4-triazol-1- yl)pentan-3-ol |
76738-62-0 |
- |
2,2-bis(bromomethyl) propane-1,3-diol |
3296-90-0 |
221-967-7 |
2-(4-tert-butylbenzyl) propionaldehyde |
80-54-6 |
201-289-8 |
Diisooctyl phthalate |
27554-26-3 |
248-523-5 |
2-methoxyethyl acrylate |
3121-61-7 |
221-499-3 |
Sodium N-(hydroxymethyl)glycinate; [formaldehyde released from sodium N-(hydroxymethyl)glycinate] |
70161-44-3 |
274-357-8 |
Pyrithione zinc; (T-4)- bis[1-(hydroxy-.kappa.O)pyridine-2(1H)- thionato-.kappa.S]zinc |
13463-41-7 |
236-671-3 |
Flurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one |
61213-25-0 |
262-661-3 |
3-(difluoromethyl)-1- methyl-N-(3',4',5'-trifluorobiphenyl-2-yl) pyrazole-4-carboxamide; fluxapyroxad |
907204-31-3 |
- |
N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA] |
924-42-5 |
213-103-2 |
5-fluoro-1,3-dimethyl-N-[2-(4- methylpentan-2-yl) phenyl]-1H-pyrazole- 4-carboxamide; 2'- [(RS)-1,3-dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen |
494793-67-8 |
- |
Iprovalicarb (ISO); isopropyl [(2S)-3- methyl-1-{[1-(4- methylphenyl)ethyl] amino}-1-oxobutan-2- yl]carbamate |
140923-17-7 |
- |
Dichlorodioctylstannane |
3542-36-7 |
222-583-2 |
Mesotrione (ISO); 2-[4-(methylsulfonyl)- 2-nitrobenzoyl]-1,3- cyclohexanedione |
104206-82-8 |
- |
Hymexazol (ISO); 3-hydroxy-5-methylisoxazole |
10004-44-1 |
233-000-6 |
Imiprothrin (ISO); reaction mass of: [2,4- dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-trans-chrysanthemate |
72963-72-5 |
428-790-6 |
Bis(α,α-dimethylbenzyl) peroxide |
80-43-3 |
201-279-3 |
* Commission Regulation :
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32021R1902
출처: Chemical Watch